| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.19 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.04 |